Mozart Therapeutics adds $25M to earlier Series A round

The funding follows a $55 million round the Seattle-based biotech raised nearly two years ago for its autoimmune and inflammatory disease treatments.

Source: bizjournals.com Health Care:Physician Practices headlines - June 7, 2023 Category: American Health Authors: Rick Morgan Source Type: news